Jerzy Windyga

20PUBLICATIONS
78CO-AUTHORS
Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyAnimal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 24, 2026
Guidelines for Minimizing Bleeding Risk During Bronchoscopic Procedures.

|Jul 17, 2026
Denecimig (Mim8) prophylaxis once-every-2-weeks for hemophilia A with or without inhibitors - 26-week results from FRONTIER.

|Jun 24, 2026
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cut-off results of the phase 3 explorer8 study.

|Jul 17, 2025
Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors.

Manuel Carcao, Cédric Hermans, Adam Giermasz

|Jul 20, 2024
Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional study.

Jerzy Windyga, Shashikant Apte, Melissa Frei-Jones

|Feb 06, 2024
Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study.

Christian Pfrepper, Paolo Radossi, Jerzy Windyga

Pageof 4

Frequent Collaborators

5 joint publications

Johnny N Mahlangu

3 joint publications

Guy Young

2 joint publications

Ingrid Pabinger-Fasching

2 joint publications

Jan Astermark